Ligand Announces Positive Top Line Results from Phase 1 Clinical Trial of Captisol-enabled Iohexol Read more
Celsius Therapeutics Signs Collaboration Agreement with Janssen to Identify Response Biomarkers for Ulcerative Colitis Read more
MacroGenics and I-Mab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Enoblituzumab in Greater China Read more
ReachBio Research Labs Offers New Services for ADC Off-target Toxicity and Linker Stability Read more
CytomX Therapeutics Announces Second Target Selection and Program Initiation with AbbVie Under Ongoing Read more
Extensive expansion at Lonza’s Tampa site provides streamlined services for solid oral dosage forms Read more
NeuroRx Initiates Pivotal Study for NRX-101, a Breakthrough Designation Therapy Targeting Suicidal Bipolar Depression Read more
Altimmune Signs Definitive Agreement to Acquire Spitfire Pharma, Inc. Adding NASH Drug Candidate to Portfolio Read more